Autopsy report · NCT01348711

Early Placental Insufficiency Screening

“Shortness inclusions of patients”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 9 months after it had already started.
• Ran for about 4 years before it stopped.
• 226 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

University Hospital, Tours

Sponsor type

University, hospital or other

Conditions

Pre-eclampsia

Participants

226

Sites

4

Countries

France

Trials that died the same way

• Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism
  “Due to slow inclusion of patients” (69% match in meaning)
• Endothelial Protection in Convalescent COVID-19 Patients
  “Lack of the eligible patients” (59% match in meaning)
• Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer
  “Too narrow inclusion criteria. Impossible to recruit patients.” (59% match in meaning)
• Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin Therapy
  “Failure to include patients” (59% match in meaning)
• Cetrotide Treatment Optimization
  “Due to limited rate of patient inclusion” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.